p53 Deficiency leads to compensatory up-regulation of p16INK4a

Wai Fook Leong1, Jenny Fung Ling Chau, Baojie Li

  • 1Cancer and Developmental Biology Division, The Institute of Molecular and Cell Biology, Agency for Science, Technology, and Research, Singapore.

Insights

The tumor suppressor p53 normally represses p16(INK4a) expression. Loss of p53 function leads to increased p16(INK4a) via Ets1, suggesting a compensatory mechanism in cancer therapy.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Cell Cycle Regulation

Background:

  • The p53-p21-cyclin-dependent kinase and p16(INK4a)-cyclin-dependent kinase pathways are crucial for preventing tumor formation.
  • Tumor suppressor p53 is often inactivated in cancer, while p16(INK4a) is frequently silenced by promoter methylation.
  • The interplay between the p53 and p16(INK4a) pathways in tumorigenesis remains incompletely understood.

Purpose of the Study:

  • To elucidate the regulatory relationship between p53 and p16(INK4a) expression.
  • To investigate the mechanisms underlying p16(INK4a) dysregulation in the absence of functional p53.
  • To identify potential therapeutic targets based on the interaction between these pathways.

Main Methods:

  • Analysis of p16(INK4a) expression and promoter activity in p53-deficient and wild-type mouse embryonic fibroblasts, osteoblasts, and organs.
  • Assessment of p16(INK4a) regulation upon p53 reconstitution and in response to genotoxic stress or nutlin-3.
  • Investigation of the role of Ets1 in mediating p16(INK4a) up-regulation in p53-deficient cells using knockdown experiments.

Main Results:

  • p53 deficiency led to increased p16(INK4a) expression and promoter activity in various cell types and organs.
  • Functional p53, but not mutant p53, restored normal p16(INK4a) levels, indicating p53's role in repressing p16(INK4a).
  • p53's repression of p16(INK4a) was found to be necessary but not sufficient, with Ets1 identified as a key mediator of p16(INK4a) up-regulation in p53-deficient cells.

Conclusions:

  • p53 plays a critical role in suppressing p16(INK4a) expression, and its loss leads to compensatory up-regulation of p16(INK4a).
  • The transcription factor Ets1 mediates the elevated p16(INK4a) levels observed in p53-deficient cells.
  • These findings reveal a compensatory mechanism that could be exploited for combined targeting of p53 and p16(INK4a) in cancer therapy.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...